Homepage - Ophthalmology Advisor
Researchers and experts detail the links between ocular conditions and attention deficit hyperactivity disorder, as well as its associated behaviors such as chronic eye rubbing, in both children and adults.
FDA Alerts: Ophthalmology Drug and Device Approvals
Feb 20, 2024 · Drug Regulatory Updates. Susvimo: Diabetic Eye Conditions. The FDA has accepted the application for Susvimo ® (ranibizumab injection, Genentech) to treat diabetic macular edema (DME) and diabetic retinopathy (DR) based on 1-year Pagoda and Pavilion study data. 3 Susvimo is a refillable implant that delivers medication continuously. 3. Based on 2 years of Phase 3 data presented at American ...
Ophthalmology Advisor Redesign: New Look, Better Access, …
Welcome to the new Ophthalmology Advisor! As you can see, we’ve completely redesigned the site with a sleeker, more modern feel to better fit our top-quality and comprehensive eye care coverage.
Direct Selective Laser Trabeculoplasty Lowers IOP in OAG, OHT ...
Oct 18, 2024 · Direct selective laser trabeculoplasty (DSLT) is well tolerated and provides a significant reduction in intraocular pressure (IOP) for up to 12 months in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT), according to research presented at the American Academy of Ophthalmology 2024 annual meeting, held in …
FDA Alerts: Ophthalmology Drug and Device Approvals
Jan 15, 2025 · A frequently updated review of the latest announcements and approvals from the FDA concerning ophthalmology. When in the hands of a skilled clinician, modern medical devices and pharmaceuticals can drive breakthroughs in ophthalmic diagnosis and treatment. The US Food and Drug Administration (FDA ...
Angle Closure Treatment and Monitoring: Update Your Practice ...
The clinical management of primary angle closure disease has been a rapidly evolving topic in recent years. The advent of new technologies, such as anterior segment optical coherence tomography (AS-OCT), has enabled the ability to address clinical questions that were previously unanswerable.Simultaneously, new research has yielded evidence and insights that have helped to reshape practice ...
Age-Related Macular Degeneration - Ophthalmology Advisor
Jan 20, 2025 · Age-related macular degeneration (AMD), an acquired retinal disease that affects the macula, is the most common cause of irreversible vision loss in older adults 1, who represent the fastest-growing demographic group in the United States (US) 2.. Overall, AMD is responsible for approximately 46% of cases of severe vision loss (visual acuity 20/200 or worse) in …
Photobiomodulation: An Emerging Dry AMD Treatment
Mar 20, 2024 · A Future in AMD Management. There are some limitations in comparing these results to other photobiomodulation studies, including varying wavelengths, time intervals of treatment , and length of sessions across different studies, as well as lack of specificity regarding which stage of AMD the treatment is best targeted towards.
In Glaucoma Management, Less is More - Ophthalmology Advisor
Apr 23, 2021 · A riddle stands at the center of glaucoma care. Research indicates that, when intraocular pressure (IOP) is substantially lowered, disease progression can be halted. 1 Yet, multiple studies show that, despite adequate lowering of IOP, disease progression still occurs. 2,3 How do we reconcile this apparent paradox? Why do medicated patients continue to progress despite IOPs that are low enough ...
Half-Dose Photodynamic Treatment Improves Acute CSCR
Jan 7, 2025 · Acute central serous chorioretinopathy (CSCR) often self-resolves, but among many treatment methods, half-dose photodynamic therapy (PDT) appears to offer robust anatomic improvement, with several other approaches showing less consistent results, according to a report by the American Academy of Ophthalmology (AAO). The study also shows that tackling systemic Helicobacter pylori infection may ...